Ripley Rosemary L's Form 4 filing
Zevia PBCZVIA · filed Dec 9, 2024
- Accession no.
- 0001415889-24-028726
- Filed
- Dec 9, 2024
- Trade date
- Dec 5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $4.88M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ripley Rosemary LCIK 0001829141 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Class A Common Stock | SSaleDisposed | −2,567,006 | $1.90F3 | −$4,877,311.4 | 2,719,258 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
NGEN III sold 2,567,006 shares of restricted Class A Common Stock in a private block trade at a price of $1.8996 per share as determined by the 20-day Volume Weighted Average Price ("VWAP") as of the market close on December 02, 2024. The transfer was effected on or about December 5, 2024.
Referenced by the price of 1 transaction in Table I.